Antithrombotic treatment in atrial fibrillation.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16159980.
- Also identified by PMC identifier 1860779.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atrial fibrillation (AF) is the most common sustained arrhythmia, that substantially increases morbidity and mortality. AF is gaining in clinical and economic importance, with stroke and thromboembolism being major complications. In this article, the evidence for AF treatment trial of antithrombotic therapy is reviewed. Stroke risk stratification of patients with AF is discussed, and practical recommendations for thromboprophylaxis are presented.
Medical subject headings
- Atrial Fibrillation
- Fibrinolytic Agents